Search company, investor...


Founded Year



Series A | Alive

Total Raised


Last Raised

$6.25M | 15 yrs ago

About CS-Keys

CS-Keys, LLC is creating cancer-specific biomarkers using advanced protein chemistry technologies (proteomics). The company is developing a new series of diagnostics to detect the occurrence or re-occurrence of cancer leading to more effective individualized treatment strategies for primary and metastatic disease, with an initial focus on breast cancer.

Headquarters Location

2461 Directors Row Suite K

Indianapolis, Indiana, 46241,

United States


Missing: CS-Keys's Product Demo & Case Studies

Promote your product offering to tech buyers.

Reach 1000s of buyers who use CB Insights to identify vendors, demo products, and make purchasing decisions.

Missing: CS-Keys's Product & Differentiators

Don’t let your products get skipped. Buyers use our vendor rankings to shortlist companies and drive requests for proposals (RFPs).

Expert Collections containing CS-Keys

Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.

CS-Keys is included in 1 Expert Collection, including Omics.



1,267 items

Companies involved in the capture, sequencing, and/or analysis of genomic, transcriptomic, proteomic, and/or metabolomic data

CS-Keys Patents

CS-Keys has filed 1 patent.

patents chart

Application Date

Grant Date


Related Topics




DNA replication, DNA repair, Transcription factors, Sensors


Application Date


Grant Date



Related Topics

DNA replication, DNA repair, Transcription factors, Sensors



CS-Keys Frequently Asked Questions (FAQ)

  • When was CS-Keys founded?

    CS-Keys was founded in 2006.

  • Where is CS-Keys's headquarters?

    CS-Keys's headquarters is located at 2461 Directors Row, Indianapolis.

  • What is CS-Keys's latest funding round?

    CS-Keys's latest funding round is Series A.

  • How much did CS-Keys raise?

    CS-Keys raised a total of $6.54M.

  • Who are the investors of CS-Keys?

    Investors of CS-Keys include Triathlon Medical Venture Partners, Prolog Ventures, Spring Mill Venture Partners, Ceres Venture Fund, CHV Capital and 4 more.

  • Who are CS-Keys's competitors?

    Competitors of CS-Keys include CivaTech Oncology, SomaLogic, Decipher Biosciences, Foundation Medicine, Orison and 9 more.

Compare CS-Keys to Competitors

Micrima Logo

Micrima is a Bristol-based company developing a safe, low-cost system to improve the detection of breast cancer. The imaging system captures high-resolution, 3D images through the use of harmless radio waves. The safe, low-cost system enables women of all ages to be screened for breast cancer in GP surgeries, or alternative high street locations, with results that are now comparable with traditional X-ray mammograms.

Manoa Medical

Manoa Medical develops an advanced method of diagnosis and treatment of breast cancer.

Microwave Imaging System Technologies (MIST)

Microwave Imaging Systems Technology was founded in 1995 by Dr. Keith Paulsen and Dr. Paul Meaney of the Thayer School of Engineering and has developed a microwave-based, breast imaging system which aims to provide high-contrast images for breast cancer diagnostics. Per the company, the NIH has invested more than $6 million to develop and demonstrate the MIST system for tumor imaging. The company reports that testing on more than 150 patients has shown excellent detection of breast tumors.

Daktari Diagnostics Logo
Daktari Diagnostics

Daktari Diagnostics develops products that deliver critical diagnostic information to clinicians and patients. Daktari's initial product is a handheld CD4 cell counter that aims to enable CD4 counting to be done by anyone. The company intends to bring this blood test to parts of the world where millions of people now have access to life-saving drugs, yet cannot begin treatment due to inadequate diagnostics.

TechniScan Medical Systems

TechniScan has developed a whole breast ultrasound imaging system

Michelson Diagnostics

Michelson Diagnostics (MDL) is a UK-based independent company with products based on an optical imaging technology, called 'Multi-Beam OCT'. The company is primarily targeting cancer (screening, diagnosis, staging, treatment planning and guidance, and monitoring), but the products are also finding applications in commercial skin products research, in genetics (developmental biology) and in industrial metrology.

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.